Proteasomes in apoptosis: Villains or guardians?

Cellular and Molecular Life Sciences

Volumn 56, Issue 11-12, 1999, Pages 908-917

  Wojcik C ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apoptosis; Caspases; Programmed cell death; Proteasome; Ubiquitin

Indexed keywords

HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; POLYAMINE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

APOPTOSIS; PROTEIN DEGRADATION; REVIEW;

ANIMALS; APOPTOSIS; CYSTEINE ENDOPEPTIDASES; HUMANS; INSECTS; MULTIENZYME COMPLEXES; MUSCLES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS;

EID: 0033376668     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050483     Document Type: Review

References (110)

1. 1 Solary E., Eymin B., Droin N. and Haugg M. (1998) Proteases, proteolysis and apoptosis. Cell Biol. Toxicol. 14: 121-132
2. 2 Green D. R. (1998) Apoptotic pathways: the roads to ruin. Cell 94: 695-698
3. 3 Varshavsky A. (1997) The ubiquitin system. Trends Biochem. Sci. 22: 383-387
4. 4 Tanaka K. (1998) Proteasomes: structure and biology. J. Biochem. 123: 195-204
5. 5 Drexler H. C. A. (1998) Programmed cell death and the proteasome. Apoptosis 3: 1-7
6. 6 Grimm L. M. and Osborne B. A. (1999) Apoptosis and the proteasome. Results Probl. Cell Differ. 23: 209-228
7. 7 Roek K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L. et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771
8. 8 Piedimonte G., Crinelli R., Salda L. D., Corsi D., Pennisi M. G., Kramer L. el al. (1999) Protein degradation and apoptotic death in lymphocytes during Fiv infection: activation of the ubiquitin-proteasome proteolytic system. Exp. Cell Res. 248: 381-390
9. 9 Beyette J., Mason G. G., Murray R. Z., Cohen G. M. and Rivett A. J. (1998) Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. Biochem. J. 332: 315-320
10. 10 Wojcik C., Mlynarczuk I., Hoser G., Kawiak J., Stoklosa T., Golab J. et al. (1999) A combination of retinoic acid and proteasome inhibitors for the treatment of leukemias is potentially dangerous. Blood 94: 1827-1828
11. 11 Sadoul R., Fernandez P. A., Quiquerez A. L., Martinou I., Maki M., Schroter M. et al. (1996) Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15: 3845-3852
12. 12 Lin K. I., Baraban J. M. and Ratan R.R. (1998) Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration. Cell Death Differ. 5: 577-583
13. 13 Schwartz L. M., Myer A., Kosz L., Engelstein M. and Maier C. (1990) Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron 5: 411-419
14. 14 Delic J., Morange M. and Magdelenat H. (1993) Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis. Mol. Cell. Biol. 13: 4875-4883
15. 15 Lauzon R. J., Patton C. W. and Weissman I. L. (1993) A morphological and immunohistochemical study of programmed cell death in Botrytllus schlosseri (Tunicata, Ascidiacea). Cell Tiss. Res. 272: 115-127
16. 16 Migheli A., Attanasio A. and Schiffer D. (1994) Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis. Neuropathol. Appl. Neurobiol. 20: 282-289
17. 17 Phillips M. E. and Platt J. E. (1994) The use of ubiquitin as a marker of thyroxine-induced apoptosis in cultured Rana catesbeiana tail tips. Gen. Comp. Endocrinol. 95: 409-415
18. 18 Fahrbach S. E. and Schwartz L. M. (1994) Localization of immunoreactive ubiquitin in the nervous system of the Manduca sexta moth. J. Comp. Neurol. 343: 464-482
19. 19 Tanimoto Y., Onishi Y., Hashimoto S. and Kizaki H. (1997) Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. 121: 542-549
20. 20 Soldatenkov V. A. and Dritsehilo A. (1997) Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. Cancer Res. 57: 3881-3885
21. 21 Soldatenkov V. A., Prasad S., Voloshin Y. and Dritschilo A. (1998) Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ. 5: 307-312
22. 22 Mello S. and Galli C. (1993) SGP2, ubiquitin, 14K lectin and RP8 mRNAs are not induced in neuronal apoptosis. Neuroreport 4: 355-358
23. 23 Marushige Y. and Marushige K. (1995) Disappearance of ubiquitinated histone H2A during chromatin condensation in TGF beta 1-induced apoptosis. Anticancer Res. 15: 267-272
24. 24 Young F. M., Illingworth P. J. and Fraser H. M. (1998) Ubiquitin and apoptosis in the corpus luteum of the marmoset monkey (Cullithrix jacchus). J. Reprod. Fertil. 114: 163-168
25. 25 Dawson S. P., Arnold J. E., Mayer N. J., Reynolds S. E., Billett M. A., Gordon C. et al. (1995) Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J. Biol. Chem. 270: 1850-1858
26. 26 Haas A. L., Baboshina O., Williams B. and Schwartz L. M. (1995) Coordinated induction of the ubiquitin conjugation pathway accompanies the developmentally programmed death of insect skeletal muscle. J. Biol. Chem. 270: 9407-9412
27. 27 Jones M. E., Haire M. F., Kloetzel P. M., Mykles D. L. and Schwartz L. M. (1995) Changes in the structure and function of the multicatalytic proleinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta. Dev. Biol. 169: 436-447
28. 28 Low P., Bussell K., Dawson S. P., Billett M. A., Mayer R. J. and Reynolds S. E., (1997) Expression of a 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta. FEBS Lett. 400: 345-349
29. 29 Machiels B. M., Henfling M. E., Schutte B., van Engeland M., Broers J. L. and Ramaekers F. C. (1996) Subcellular localization of proteasomes in apoptotic lung tumor cells and persistence as compared to intermediate filaments. Eur. J. Cell Biol. 70: 250-259
30. 30 Amsterdam A., Dantes A., Selvaraj N. and Aharoni D. (1997) Apoptosis in steroidogenic cells: structure-function analysis. Steroids 62: 207-211
31. 31 Baudet C., Perret E., Delpech B., Kaghad M, Brachet P., Wion D. et al. (1998) Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program. Cell Death Differ. 5: 116-125
32. 32 Nakajima T., Morita K., Ohi N., Arai T., Nozaki N., Kikuchi A. et al. (1996) Degradation of topoisomerase II alpha during adenovirus EIA-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J. Biol. Chem. 271: 24842-24849
33. 33 Nakajima T., Kimura M., Kuroda K., Tanaka M., Kikuchi A., Seino H. et al. (1997) Induction of ubiquitin conjugating enzyme activity for degradation of topoisomerase II alpha during adenovirus EIA-induced apoptosis. Biochem. Biophys. Res. Commun. 239: 823-829
34. 34 Lesche R., Peetz A., van der Hoeven F. and Ruther U. (1997) Ftl, a novel gene related to ubiquitin-conjugating enzymes, is deleted in the Fused toes mouse mutation. Mamm. Genome 8: 879-883
35. 35 Harvey K. F., Harvey N. L., Michael J. M., Parasivam G., Waterhouse N. and Alnemri E. S. (1998) Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis. J. Biol. Chem. 273: 13524-13530
36. 36 Hauser H. P., Bardroff M., Pyrowolakis G. and Jentseh S. (1998) A giant ubiquitin-conjugaling enzyme related to IAP apoptosis inhibitors. J. Cell Biol. 141: 1415-1422
37. 37 Boldin M. P., Mett I. L. and Wallach D. (1995) A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 367: 39-44
38. 38 Tsurumi C., Shimizu Y., Saeki M., Kato S., Demartino G. N., Slaughter C. A. et al. (1996) cDNA cloning and functional analysis of the p97 subunit of the 26s proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11. Eur. J. Biochem. 239: 912-921
39. 39 Wright D. A., Futcher B., Ghosh P. and Geha R. S. (1996) Association of human fas (CD95) with a ubiquitin-conjugating enzyme (UBC-FAP). J. Biol. Chem. 271: 31037-31043
40. 40 Becker K., Schneider P., Hofmann K., Mattmann C. and Tschopp J. (1997) Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway. FEBS Lett. 412: 102-106
41. 41 Okura T., Gong L., Kamitani T., Wada T., Okura I., Wei C. F. et al. (1996) Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157: 4277-4281
42. 42 Liou M. L. and Liou H. C. (1999) The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis. J. Biol. Chem. 274: 10145-10153
43. 43 Frohlieh T., Risau W. and Flamme I. (1998) Characterization of novel nuclear targeting and apoptosis-inducing domains in FAS associated factor I. J. Cell Sci. 111: 2353-2363
44. 44 Thompson E. B. (1998) The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 60: 575-600
45. 45 Gross-Mesilaty S., Reinstein F., Bercovich B., Tobias K. E., Schwartz A. L., Kahana C. et al. (1998) Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. 95: 8058-8063
46. 46 Save V., Nylander K. and Hall P. A. (1998) Why is p53 protein stabilized in neoplasia? Some answers but many more questions? [editorial]. J. Pathol. 184: 348-350
47. 47 Kubbutat M. H. G. and Vousden K. H. (1998) Keeping an old friend under control: regulation of p53 stability. Mol. Med. Today 2: 250-256
48. 48 Fuchs S. Y., Adler V., Pincus M. R. and Ronai Z. (1998) MEKKI/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. 95: 10541-10546
49. 49 Labrecque S. and Matlashewski G. J. (1995) Viability of wild-type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53. Oncogene 11: 387-392
50. 50 Lopes U. G., Erhardt P., Yao R. and Cooper G. M. (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272: 12893-12896
51. 51 Chang Y. C., Lee Y. S., Tejima T., Tanaka K., Omura S., Heintz N. H. et al. (1998) mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 9: 79-84
52. 52 Matsuzawa S., Takayama S., Froesch B. A., Zapata J. M. and Reed J. C. (1998) p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by Bag-1. EMBO J. 17: 2736-2747
53. 53 Wójcik C. (1999) Inhibition of the proteasome as a therapeutic approach. Drug Disc. Today 4: 188-192
54. 54 Lee D. H. and Goldberg A. L. (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403
55. 55 Imajoh-Ohmi S., Kawaguchi T., Sugiyama S., Tanaka K., Omura S. and Kikuchi H. (1995) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217: 1070-1077
56. 56 Shinohara K., Tomioka M., Nakano H., Tone S., Ito H. and Kawashima S. (1996) Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317: 385-388
57. 57 Wojcik C., Schroeter D., Stoehr M., Wilk S. and Paweletz N. (1996) An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells. Eur. J. Cell Biol. 70: 172-178
58. 58 Wojcik C., Stoklosa T., Giermasz A., Golab J., Zagozdzon R., Kawiak J. et al. (1997) Apoptosis induced in L1210 leukemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome. Apoptosis 2: 455-462
59. 59 An B., Goldfarb R. H., Siman R. and Dou Q. P. (1998) Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ. 5: 1062-1075
60. 60 Orlowski R. Z., Eswara J. R., Lafond-Walker A., Grever M. R., Orlowski M. and Dang C. V. (1998) Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res. 58: 4342-4348
61. 61 Murphy M. P. (1999) Nitric oxide and cell death. Biochim. Biophys. Acta 1411: 401-414
62. 62 Glockzin S., von Knethen A., Scheffner M. and Brüne B. (1999) Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274: 19581-19586
63. 63 Grimm L. M., Goldberg A. L., Poirier G. G., Schwartz L. M. and Osborne B. A. (1996) Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15: 3835-3844
64. 64 Cui H., Matsui K., Omura S., Schauer S. L., Matulka R. A., Sonenshein G. F. et ul. (1997) Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. 94: 7515-7520
65. 65 He H., Qi X. M., Grossmann J. and Distelhorst C. W. (1998) c-Fos degradation by the proteasome. an early, Bcl-2-regulated step in apoptosis. J. Biol. Chem. 273: 25015-25019
66. 66 Martinou I., Missotten M., Fernandez P. A., Sadoul R. and Martinou J. C. (1998) Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons. Neuroreport 9: 15-19
67. 67 Boutillier A. L., Kienlen-Campard P. and Loeffler J. P. (1999) Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway. Eur. J. Neurosci. 11: 441-448
68. 68 Stefanelli C., Bonavita F., Stanic I., Pignatti C., Farruggia G., Masotti L. et al. (1998) Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome. Biochem. J. 332: 661-665
69. 69 Hirsch T., Dallaporta B., Zamzami N., Susin S. A., Ravagnan L., Marzo I. et al. (1998) Proteasome activation occurs al an early, premitochondrial step of thymocyte apoptosis. J. Immunol. 161: 35-40
70. 70 Traenckner E. B., Wilk S. and Baeuerle P. A. (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13: 5433-5441
71. 71 Wang C. Y., Mayo M. W. and Baldwin A. S. Jr. (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NFkB. Science 274: 787-789
72. 72 Fujita E., Mukasa T., Tsukahara T., Arahata K., Omura S. and Momoi T. (1996) Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem. Biophys. Res. Commun. 224: 74-79
73. 73 Delic J., Masdehors P., Omura S., Cosset J. M., Dumont J., Binet J. L. et al. (1998) The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo-and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br. J. Cancer 77: 1103-1107
74. 74 Ruckdeschel K., Harb S., Roggenkamp A., Hornef M., Zumbihl R., Kohler S. et al. (1998) Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J. Exp. Med. 187: 1069-1079
75. 75 Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T. and Debatin K. M. (1998) Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91: 4624-4631
76. 76 Meriin A. B., Gabai V. L., Yaglom J., Shifrin V. I. and Sherman M. Y. (1998) Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J. Biol. Chem. 273: 6373-6379
77. 77 Stoklosa T., Wójcik C., Golab J., Giermasz A. and Wilk S. (1999) Inhibition of proteasome, apoptosis and sensitization to tumour necrosis factor alpha: do they always go together? Br. J. Cancer 79: 375-376
78. 78 Rapp L. and Chen J. J. (1998) The papillomavirus E6 proteins. Biochim. Biophys. Acta 1378: F1 19
79. 79 Xu C., Meikrantz W., Schlegel R. and Sager R. (1995) The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proc. Natl. Acad. Sci. 92: 7829-7833
80. 80 Kitagawa H., Tani E., Ikemoto H., Ozaki I., Nakano A. and Omura S. (1999) Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett. 443: 181-186
81. 81 Monney L., Otter I., Olivier R., Ozer H. L., Haas A. L., Omura S. and Borner C. (1998) Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273: 6121-6131
82. 82 Herrmann J. L., Briones F., Brisbay S. Jr., Logothetis C. J. and McDonnell T. J. (1998) Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Oncogene 17: 2889-2899
83. 83 Zhang X., Lin H., Chen C. and Chen B. D. (1999) Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07c leukaemic cells. Biochem. J. 340: 127-133
84. 84 Dimmeler S., Breitschopf K., Haendeler J. and Zeiher A. M. (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189: 1815-1822
85. 85 Kobayashi T., Shinozaki A., Momoi T., Arahata K. and Tsukahara T. (1996) Identification of an interleukin-1 beta converting enzyme-like activity that increases upon treatment of P19 cells with retinoic acid as the proteasome. J. Biochem. 120: 699-704
86. 86 Wu L. W., Reid S., Ritchie A., Broxmeyer H. E. and Donner D. B. (1999) The proteasome regulates caspase-dependent and caspase-independent protease cascades during apoptosis of MO7e hematopoietic progenitor cells. Blood Cells Mol. Dis. 25: 20-29
87. 87 Murakami Y., Matsufuji S., Kameji T., Hayashi S., Igarashi K., Tamura T. et al. (1992) Ornilhine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360: 597-599
88. 88 Grassilli E., Benatti F., Dansi P., Giammarioli A. M., Malorni W., Franceschi C. et al. (1998) Inhibition of proteasome function prevents thymocyte apoptosis: involvement of ornithine decarboxylase. Biochem. Biophys. Res. Commun. 250: 293-297
89. 89 Volloch V., Mosser D. D., Massie B. and Sherman M. Y. (1998) Reduced thermotolerance in aged cells results from a loss of an hsp72-mediated control of JNK signaling pathway. Cell Stress Chaperones 3: 265-271
90. 90 Dou Q. P., McGuire T. F., Peng Y. and An B. (1999) Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells. J. Pharmacol. Exp. Ther. 289: 781-790
91. 91 Drexler H. C. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. 94: 855-860
92. 92 Pagano M., Tam S. W., Theodoras A. M., Beer-Romero P., Del Sal G., Chau V. et al. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [see comments]. Science 269: 682-685
93. 93 Lloyd R. V., Erickson L. A., Jin L., Kulig E., Qian X., Cheville J. C. et al. (1999) p27kipl: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154: 313-323
94. 94 Loda M., Cukor B., Tam S. W., Lavin P., Fiorentino M., Draetta G. F. et al. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3: 231-234
95. 95 Orlowski R. Z. (1999) The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ. 6: 303 313
96. 96 Wang X., Luo H., Chen H., Duguid W. and Wu J. (1998) Role of proteasomes in T cell activation and proliferation. J. Immunol. 160: 788-801
97. 97 Masdehors P., Omura S., Merle BrH., Mentz F., Cosset J. M., Dumont J. et al. (1999) Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin. Br. J. Haematol. 105: 752-757
98. 98 Spinedi A., Oliverio S., Di Sano F. and Piacentini M. (1998) Calpain involvement in calphostin C-induced apoptosis. Biochem. Pharmacol. 56: 1489-1492
99. 99 Osmulski P. A. and Gaczynska M. (1998) A new large proteolytic complex distinct from the proteasome is present in the cytosol of fission yeast. Curr. Biol. 8: 1023-1026
100. 100 Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K. et al. (1999) A giant protease with potential to substitute for some functions of the proteasome. Science 283: 978-981
101. 101 Squier M. K., Sehnert A. J., Sellins K. S., Malkinson A. M., Takano E and Cohen J. J. (1999) Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 178: 311-319
102. 102 Selleri C., Sato T., Raiola A. M., Rotoli B., Young N. S. and Maciejewski J. P. (1997) Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br. J. Haematol. 99: 481-489
103. 103 Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T. and Davies K. J. (1999) Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. 96: 6223-6228
104. 104 Pieper A. A., Verma A., Zhang J. and Snyder S. H. (1999) Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20: 171-181
105. 105 Bohlinger I., Leist M., Barsig J., Uhlig S.,Tiegs G. and Wendel A. (1995) Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology 22: 1829-1837
106. 106 Matthys P., Froyen G., Verdot L., Huang S., Sobis H., Van Damme J. et al. (1995) IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J. Immunol. 155: 3823-3829
107. 107 Lazebnik Y. A, Kaufmann S. H., Desnoyers S., Poirier G. G. and Earnshaw W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347
108. 108 Adams J., Palombella V. J., Sausville E. A., Johnson J., Destree A., Lazarus D. D. et al. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59: 2615-2622
109. 109 Meng L., Kwok B. H., Sin N. and Crews C. M. (1999) Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res. 59: 2798-2801
110. 110 Bonn D. (1999). Targeting protein breakdown to treat cancer. Molec. Med. Today 48-49